CoChat

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity

Open access
Cichocki, Frank, Valamehr, Bahram, Bjordahl, Ryan, Zhang, Bin, Rezner, Betsy, Rogers, Paul, Gaidarova, Svetlana, Moreno, Stacey, Tuininga, Katie, Dougherty, Phillip, McCullar, Valarie, Howard, Peter, Sarhan, Dhifaf, Taras, Emily, Schlums, Heinrich, Abbot, Stewart, Shoemaker, Daniel, Bryceson, Yenan T., Blazar, Bruce R., Wolchko, Scott, Cooley, Sarah, Miller, Jeffrey S. · 2017 · Cancer Research
Cited by 151

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Maturation of human natural killer (NK) cells as defined by accumulation of cell-surface expression of CD57 is associated with increased cytotoxic character and TNF and IFNγ production upon target-cell recognition. Notably, multiple studies point to a unique role for CD57+ NK cells in cancer immunosurveillance, yet there is scant information about how they mature. In this study, we show that pharmacologic inhibition of GSK3 kinase in peripheral blood NK cells expanded ex vivo with IL15 greatly enhances CD57 upregulation and late-stage maturation. GSK3 inhibition elevated the expression of several transcription factors associated with late-stage NK-cell maturation including T-BET, ZEB2, and BLIMP-1 without affecting viability or proliferation. When exposed to human cancer cells, NK cell expanded ex vivo in the presence of a GSK3 inhibitor exhibited significantly higher production of TNF and IFNγ, elevated natural cytotoxicity, and increased antibody-dependent cellular cytotoxicity. In an established mouse xenograft model of ovarian cancer, adoptive transfer of NK cells conditioned in the same way also displayed more robust and durable tumor control. Our findings show how GSK3 kinase inhibition can greatly enhance the mature character of NK cells most desired for effective cancer immunotherapy. Cancer Res; 77(20); 5664–75. ©2017 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-17-0799

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 151

Metadata

Authors
Cichocki, F., Valamehr, B., Bjordahl, R., Zhang, B., Rezner, B., Rogers, P., Gaidarova, S., Moreno, S., Tuininga, K., Dougherty, P., McCullar, V., Howard, P., Sarhan, D., Taras, E., Schlums, H., Abbot, S., Shoemaker, D., Bryceson, Y. T., Blazar, B. R., Wolchko, S., Cooley, S., & Miller, J. S.
Venue
Cancer Research
Published
2017-10-15
Volume
77
Issue
20
Pages
5664-5675
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2742755221
Cited by
151
References
5
FWCI
5.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity. https://app.cochat.ai/papers/10.1158/0008-5472.can-17-0799
The paper
Cichocki, F., Valamehr, B., Bjordahl, R., Zhang, B., Rezner, B., Rogers, P., Gaidarova, S., Moreno, S., Tuininga, K., Dougherty, P., McCullar, V., Howard, P., Sarhan, D., Taras, E., Schlums, H., Abbot, S., Shoemaker, D., Bryceson, Y. T., Blazar, B. R., . . . Miller, J. S. (2017). GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity. Cancer Research. https://doi.org/10.1158/0008-5472.can-17-0799

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.